Skip to main content
. 2020 Sep 10;10(9):e036748. doi: 10.1136/bmjopen-2019-036748

Figure 3.

Figure 3

Forest plots of secondary outcomes: cyclo-oxygenase-2 (COX-2) inhibitors versus traditional non-steroidal anti-inflammatory drugs (NSAIDs). Response rate for (A) days 2–8, (B) C reactive protein, (C) patient’s global assessment, (D) investigator’s global assessment and (E) inflammatory swelling. bid, two times per day; qd, one time a day; tid, three times a day; vs, versus.